Royal Bank of Canada Raises Avid Bioservices (NASDAQ:CDMO) Price Target to $12.00
Avid Bioservices (NASDAQ:CDMO – Free Report) had its target price upped by Royal Bank of Canada from $8.00 to $12.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. CDMO has been the topic of a number of other research reports. William […]
More Stories
15+ Best Thrillers on Netflix: Movies and Television Series
Do you love to watch thriller shows and movies? Here, in this blog, I have mentioned the best thrillers on...
Maternal Instinct: A True Crime Documentary will release on Netflix this June
Do you also like true crime documentaries like The Investigation of Lucy Letby and Should I Marry a Murderer? Good...
You Can’t Skip These Roblox Competitors
Roblox has introduced millions of joystick junkies and developers to the world for creating amazing games and igniting their creative...
11 Top Canadian Actors Dominating Hollywood
Jim Carrey and Nina Dobrev are among the top Canadian actors dominating Hollywood. Curious what this blog is about? Here,...
Top Female Superheroes that have Made History with Superpowers
Are you also one who thinks that a superhero means a powerful male or something like that? But superheroes don’t...
Bose Lifestyle Ultra Speaker Review 2026: Specification and Limitations
Looking for the best speaker in the market to upgrade your home? The Bose speaker is getting positive feedback from...